表紙
市場調查報告書
商品編碼
979359

平滑肌肉瘤-全球臨床試驗檢討:2020年下半年

Leiomyosarcoma Disease - Global Clinical Trials Review, H2, 2020

出版日期: | 出版商: GlobalData | 英文 241 Pages | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供平滑肌肉瘤臨床試驗方案概要。包含全世界主要國家實施的實驗數及其平均登記數概要,網羅各地區,國家(G7及E7),各期,實驗現狀,端點現狀,及各贊助商類型的疾病臨床試驗。並介紹臨床試驗進行中的主要藥物。

該報告提供了所有未完成的實驗(終止,暫停和撤回)以及未完成的原因。以及過去五年的實驗對象登記趨勢和最新的新聞。

目錄

目錄

表格清單

圖表清單

  • 報告指南
  • GlobalData臨床試驗調查範圍
  • 各地區的臨床試驗
  • 各國臨床試驗與平均登記數
  • 亞太地區對臨床試驗有貢獻的前五名國家
  • 歐洲對臨床試驗有貢獻的前五名國家
  • 北美對臨床試驗有貢獻的前幾名國家
  • 中東·非洲對臨床試驗有貢獻的前五名國家
  • 中南美對臨床試驗有貢獻的前幾名國家
  • G7各國臨床試驗:腫瘤臨床試驗上平滑肌肉瘤的比例
  • G7各國的各期的臨床試驗
  • 各臨床實驗狀況的G7各國的臨床試驗
  • E7各國臨床試驗:腫瘤臨床試驗上平滑肌肉瘤的比例
  • E7各國的各階段臨床試驗
  • E7各國臨床試驗:各臨床實驗狀況
  • 各期的臨床試驗
  • 各期的進行中的實驗
  • 各檢測狀況的臨床試驗
  • 各端點狀態臨床試驗
  • 連續一定期間所募集的實驗對象
  • 各贊助商類型的臨床試驗
  • 著名的實驗要求者
  • 平滑肌肉瘤治療參與臨床實驗的各頂尖企業
  • 著名的藥
  • 臨床試驗簡介的概述

附錄

  • 簡稱
  • 定義
  • 調查手法
  • 2次調查
  • 關於GlobalData
  • 諮詢方式
  • 來源
目錄
Product Code: GDHC6551CTIDB

GlobalData's clinical trial report, "Leiomyosarcoma Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Leiomyosarcoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Leiomyosarcoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

List of Tables

List of Figures

  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Leiomyosarcoma to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Leiomyosarcoma to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Leiomyosarcoma Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Disclaimer
  • Source

List of Tables

List of Tables

  • Leiomyosarcoma Therapeutics, Global, Clinical Trials by Region, 2020*
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, North America, Top Countries, 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2020*
  • Proportion of Leiomyosarcoma to Oncology Clinical Trials, G7 Countries (%), 2020*
  • Leiomyosarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Leiomyosarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Leiomyosarcoma to Oncology Clinical Trials, E7 Countries (%), 2020*
  • Leiomyosarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Leiomyosarcoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials by Phase, 2020*
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials In Progress by Phase 2020*
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Leiomyosarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*

List of Figures

List of Figures

  • Leiomyosarcoma Therapeutics, Global, Clinical Trials by Region (%), 2020*
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials In Progress